Clinical Trial Update: Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

View source ↗

Summary

A clinical trial in recruitment to characterize dopamine receptor binding in patients with treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: Unity Health Toronto | Conditions: Treatment Resistant Depression | Status: RECRUITING